The J chains isolated from polymeric IgA and IgM were shown to be distinct from the other immunoglobulin subunits, including the secretory component, both on the basis of amino-acid content and antigenic determinants. By the same criteria, the J chains were found to be indistinguishable from each other whether they were derived from pentamer IgM, polydisperse myeloma IgA, or dimer colostral IgA. The only differences were observed in (a) the extent of disulfide bond cleavage required for J chain release from the different polymers, and (b) the three-dimensional arrangement of J chains in the different polymers. These data support the hypothesis that the same J chain joins the monomeric units of IgA and IgM to form their respective polymeric molecules.
Two classes of immunoglobulins are characterized by polymeric structures. In both classes the polymers are assembled from IgG-like monomeric units consisting of two heavy and two light chains, linked by disulfide bonds. However, the degree of polymerization varies with the class and is a function of the distinct sequences in the respective heavy chains. Thus, IgM is predominantly pentameric, while IgA is found in the secretions as a dimer and in the serum in both monomeric and various polydisperse forms.
Although many of the structural features of the polymers have been determined (1, 2) , several critical questions remain concerning their biosynthesis. First, the linkage between the monomeric units has never been clearly established. Disulfide bonds are known to be involved, but the exact location of the bonds and the mechanism for controlled polymerization are not understood. Second, the biological significance of the polymers has not been clearly defined, but there is increasing evidence that the properties acquired through polymerization may be important in the specialized functions of IgM and IgA. For example, recent studies (3) have shown that the increased affinity achieved by the multi-attachment of IgM to the same antigen may provide effective protection during the early stages of the immune response. In the case of IgA, studies (4) have shown that the dimer is transported across epithelial barriers because of its ability to interact with the transport protein, the secretory component.
A clue to these problems was obtained when a new component, designated J chain, was found to be part of the covalent structure of human and rabbit polymeric IgA (5) . A similar component was subsequently described in human IgM (6) . Although J chain is approximately of the same size as the light chain, it was shown to be distinctly different on the basis of its amino-acid composition, peptide mapping, and antigenic properties (5, 6) . Furthermore, the J chain was found to be linked by disulfide bonds to the carboxy-terminal halves of the a and u chains, while the light chains are joined to the amino-terminal portions (7, 8) . The presence of J chain in the polymeric immunoglobulins and its absence from monomeric IgA and monomeric IgG suggested that one of its functions might be to join the monomeric units.
To ascertain its linkage role, it was necessary to show that the J chain was not an incidental fragment derived from the heavy chains or secretory component. Moreover, it was critical to establish the identity of Ja and JA and clarify the linkage mechanism in the different size polymers. In the present study, these questions were approached by isolating J chain in as native a form as possible from human IgM and IgA polymers. After purification by affinity chromatography, the J chains were analyzed for their amino-acid contents and the extent of disulfide bond cleavage. They were also used for the preparation of specific antibody to determine the immunological relationships between the J chain and the other chains, and to explore the three-dimensional arrangement of the J chain in the intact polymers. Amino-Acid Analyses were performed as described (14) .
Inhibition Tests. Anti-J antiserum was combined with intact IgM or IgA or their isolated subunits and brought to a final dilution of 1:4. When necessary, nonspecific immunoglobulin was added so that the concentration of added protein was maintained at 3.5 mg/ml. After incubation overnight at 4VC, the mixture was centrifuged to remove nonspecific precipitate. An aliquot of 1.2 ml was then removed, pipetted into a cuvette, and the amount of J chain known to give precipitation at equivalence was added. The precipitation was followed as a function of time by reading the absorbance at 460 nm in a Zeiss spectrophotometer.
RESULTS
Previous work (5) indicated that the disulfide bonds linking J to the a or u chain are relatively resistant to reductive cleavage. To isolate J chain in as native a form as possible, it was necessary to use the mildest reducing conditions that would give a good yield of J chains. Treatment with 100 mM 2-mercaptoethanol followed by alkylation with 105 mM iodoacetamide was found to be satisfactory for the myeloma IgA and IgM, but twice these reagent concentrations were required to mers were reduced under these conditions and then chromatographed on a Sephadex G-100 column equilibrated with 1 M acetic acid, at least 95% of the light-chain and 20-30% of the J chain were released. The bulk of the J chain eluted with the ascending limb of the light chain-peak. The difference in the elution positions of J and light chain was dependent on two factors: first, the slightly larger size of J, 24,500 + 1,000 daltons (15), compared to 23,000 for light chain, and second, the extent of reductive modification of the light chain. The maximum difference was achieved when only the light-heavy interchain bond was broken. As an increasing number of its intrachain bonds were reduced, the light chain eluted progressively earlier, until its peak coincided with that of J chain.
The J was separated from the light-chain mixture by use of a Sepharose column to which was conjugated the appropriate antibody to human light chain, either anti-K, anti-X, or a mixture of both. With the proper choice of sample size, all the light chain was bound to the resin and the J chain eluted at one column volume. In some preparations from myeloma and secretory IgA, small amounts of an a-chain fragment were found to cochromatograph with J chain. In these cases, the J chain was purified by an additional passage through an immunoadsorbent prepared with anti-a chain antibody.
For each polymeric serum immunoglobulin studied, aminoacid analyses were performed on the isolated J chain, the light chain eluted from the immunoadsorbent, and the monomeric heavy chain that was obtained in the acetate chromatography. In the case of colostral IgA, the heavy-chain peak contained secretory component as well as a chain. These were separated by use of an anti-a chain immunoadsorbent and then subjected to amino-acid analysis. The data from the components of a colostral IgA are presented in Table 1 to illustrate the results obtained (columns 1-4). The average composition of J chain was clearly distinct from those of the other subunits. The differences were so great, particularly in the arginine, aspartic acid, glycine, isoleucine, and half-cystine contents, that J could not be explained as a fragment from heavy chain or secretory component, or as a special type of light chain.
Furthermore, the composition of the J chain was identical, within experimental error, whether the J chain was prepared from colostral IgA, myeloma IgA, or a Waldenstrom's IgM (columns 4-6 of Table 1) .
Although the various J chain preparations had the same total half-cystine content, differences were observed in the number of half-cystines alkylated under the mildest conditions of reductive cleavage. After treatment with 100 mM 2-mercaptoethanol and 105 mM iodoacetamide, the J chain released from myeloma IgA contained an average of 8 residues of amidocarboxymethylcysteine, while the J chain released from pentamer IgM contained an average of 10 residues. No free sulfhydryl groups could be detected in the J chain by alkylation of the intact immunoglobulins, so that the difference in the amidocarboxymethylcysteine yields appeared to reflect a difference in the disulfide structure of the J chain. Thus, there are either fewer J-a chain bonds than J-,u chain bonds or the Ja intrachain bonds are more resistant to reductive cleavage.
When the concentrations of 2-mercaptoethanol and iodoacetamide were increased to 0.2 and 0.21 M, respectively, all 12 of the half-cystines were alkylated in both Ja and J,.
To study the immunological relationships between J and the other immunoglobulin subunits, antisera were prepared free any J chain from colostral IgA. When the various polyProc. Nat. Acad. Sci. USA 69 (1972) in rabbits against the partially alkylated. J chains isolated (2) colostral IgA, (3) myeloma IgA-K, (4) myeloma IgA-X and with intact myeloma IgA (5) and intact IgM (6). The J chain solutions contained 0.02 mg/ml; the intact polymers were tested at a concentration of 18 mg/ml. from an IgA-K and an IgA-X myeloma. Although the response was low, about 0.1 mg of antibody per ml of sera, the antibody had a high affinity for J and was precipitated by the addition of as little as 5 uAg of antigen per ml of sera. In preliminary precipitin tests, all the antisera were found also to give a reaction with a chain or with proteins containing a chain. This reactivity could be removed by absorption of the antisera with mildly reduced and alkylated heavy chain prepared from J-free monomer IgA. The results of Ouchterlony analyses performed with the absorbed antisera are given in Fig. 1 . The antisera were still capable of combining specifically with Ja and Jp, as indicated by the strong precipitin lines obtained. On the other hand, the antisera showed no reaction with 'c or X chains over a 100-fold range in antigen concentration (Fig. 1A) , nor with secretory component over an 80-fold antigen dilution (Fig. 1B) . The absence of crossreaction with light chain was expected, since the method of purifying J chain was based on the observation that the J chain was not bound by any antilight-chain antibody. These results provided strong evidence that the J chain is antigenically distinct from both light chain and secretory component.
The question remained whether the observed anti-a activity reflected a crossreaction between J and a chain. To test this possibility, the fraction of the anti-J antiserum that was bound to the anti-a immunoadsorbent was examined for its specificity. After elution, the fraction retained its capacity to precipitate a chain but exhibited no reaction with J chain. In a second test, 420 nmol of J chain were passed through a 10 nmol column of Sepharose beads to which were conjugated 210 nmol of anti-a antibody. Although J was exposed to a 10-fold excess of anti-a chain sites, over 97%, 41 nmol, was recovered in the eluate. In contrast, when 380 nmol of mildly reduced and alkylated a chain were applied to the same immunoabsorbent, 360 nmol were bound to the resin. The results of these two experiments indicated that J chain has no determinants in common with a chain and that the observed anti-a activity represented noncrossreacting antibody produced against a minor a chain contaminant in the J preparations used for immunization.
The Ouchterlony analyses also revealed that Ja and J, are antigenically indistinguishable from each other. As shown in Fig. 1C , a single line of indentity was obtained among the J chains isolated from a Waldenstrom's IgM, from K and X IgA myelomas, and from normal colostral IgA. The specificity was not appreciably affected by the extent of disulfide bond cleavage. In one Ja preparation, 8 half-cystines were alkylated, while in the other all 12 half-cystines were modified. Yet both preparations gave a reaction of identity with each other and with JA. Furthermore, a reaction of near identity was obtained between completely reduced and alkylated J,, and reoxidized, reformed Ja. The reoxidized, reformed J,, preparation was isolated by chromatography of IgA on a column equilibrated with reducing agent, and the S-S bonds were then allowed to reform during dialysis against buffered saline.
No precipitation was observed when the anti-J sera were tested against intact IgA or IgM that contained J chain. The results were negative even at immunoglobulin concentrations of 10-20 mg/ml (Fig. 1C) . However, the myeloma IgA or IgM was found to inhibit the reaction between J chain and its antisera. Large quantities were required because the J chain comprised such a small percentage of the whole molecule. When the J-chain concentration in the inhibitor was equal to t Moles of amino acid/peptide molecular weight. a chain = 53,000, secretory component (SC) = 67,500, light chain (L) = 23,500, and J chain = 24,000.
1 After complete reduction and alkylation; CMCys, represents amidocarboxymethylcyteine.
§ After reduction with 100 mM 2-mercaptoethanol and alkylation with 105 mM iodoacetamide. that of the test antigen, only the rate of precipitation was affected. At higher inhibitor concentrations, both the rate and the amount precipitated at equilibrium were significantly decreased. The kinetics of the inhibition determined with the same preparations of IgA and IgM, but with two different anti-J sera, are illustrated in Fig. 2 . In these experiments the total protein concentration was kept constant to avoid nonspecific solvent effects. The control precipitation was performed in the presence of 3.5 mg of bovine gamma globulin and the substitution of an equal quantity of an IgG K myeloma, and IgG X myeloma, a chain, or secretory component were found to have no effect on the reaction. The amounts of myeloma IgA and IgM were chosen so that the ratio of inhibitor J to antigen J was 30:1 and the total protein concentration was adjusted to 3.5 mg by the addition of the appropriate quantities of nonspecific immunoglobulin. The myeloma IgA and IgM blocked the reaction of J with one antiserum to an equivalent extent ( Fig. 2A) . For example, the precipitation was inhibited by 50% after 60 min of reaction time and by 20% at equilibrium. With the second antiserum (Fig. 2B) , the IgM was a poorer inhibitor than the IgA; at 60 min the amount of precipitate was decreased by 30% in the presence of IgM, compared to 60% inhibition in the presence of IgA; at equilibrium, the values were 15 and 25%, respectively.
When secretory IgA was tested under the same experimental conditions, no significant inhibition was observed. These results indicated that most of the J chain was buried within the polymeric structure of myeloma IgA or IgM. Only one or, at most, a very limited number of determinants was accessible for reaction, sufficient to bind to the anti-J serum but not to build up insoluble complexes. Furthermore, the independent patterns of inhibition obtained for IgA and IgM suggested that a different J determinant was exposed in the dimer than in the pentamer. In contrast, the J chain appeared to be completely inaccessible in secretory IgA, perhaps because of the additional blocking action of the secretory component.
DISCUSSION
When the J chain was first described, it was hypothesized to be a novel polypeptide chain because of its characteristic anodal mobility in alkaline-urea disc electrophoresis, its different amino-acid composition, and its presence only in the polymeric forms of IgA and IgM (5) . The studies presented here confirm and extend this hypothesis. First, the amino-acid composition of purified J chain was found to be so distinctive that it could not have been derived directly from any other immunoglobulin subunit. For example, J chain contains more isoleucine residues than either a or 1A chains, which are twice its size; it contains at least twice the half-cystine content of light chains and more methionines than the secretory component. Second, the J chains isolated from polymeric IgA and IgM were identical by the criteria of composition and antigenicity. Third, the J chain was shown to be antigenically distinct from the other subunits of IgA and IgM. J chain was not bound by antilight-or antiheavy-chain antibody, nor did antisera to the J chain exhibit any crossreaction with light chains, heavy chains, or secretory component. The argument might be made that the antisera were prepared against mildly reduced and alkylated J chain and thus did not recognize J or crossreacting determinants in their native conformation. This argument was invalidated when the antisera were shown to combine with the available J determinants in intact serum IgA and IgM molecules and to precipitate reoxidized, reformed J chain almost as well as the homologous, alkylated J antigen.
Because of its high content of half-cystine and charged amino-acid residues, it seems unlikely that the J chain was evolved from the same common precursor as light and heavy chains. Moreover, evidence has been obtained that the J chain arose very early in the development of the immune system, before the divergence of y chains. Studies on the single IgM-like class synthesized by the elasmobranch, the leopard shark, have shown that J is present in the 19S, but absent from the 7S form (16) . Thus, it would appear that in the evolution of the a and , chains, structures were selected that could form covalent S-S links with the J chain. It would be of considerable interest to determine whether these structures were lost in the evolution of the -y chain or whether the switchover from IgM or IgA to IgG synthesis involves the coordinate turning off of the gene responsible for J chain production.
The proposal that the J chain has a joining function has been supported by quantitative determinations of its stoichiometry that showed one J chain per polymer independent of the size of the polymer (15) . Additional support was obtained in the present studies. In the isolation of J chain, it was found necessary to modify 8 of the 12 half-cystines in Ja and 10 of the 12 half-cystines in J., before appreciable amounts were released from the respective polymers. Since interchain S-S bonds are more susceptible to reduction under the conditions used, these results indicated that J was joined to the heavy chains by multiple disulfide bridges and that the number of bonds was sufficient to allow J to be joined to each heavy chain in the polymer. Moreover, the difference in the number of half-cystines modified in Ja and J,1 suggested that the disulfide bonds can be alternately arranged so that the same J chain can function in the formation of various size polymers. The concept of a J chain bridging each heavy chain would require J to be a linear molecule. Evidence for such a structure was obtained when the antigenic specificity of the J chain was found to be quite independent of the extent of half-cystine modification. Since the S-S bonds do not contribute significantly to the conformation of the antigenic determinants, the J molecule must be sufficiently stretched out to separate the disulfide bridges from the residues that determine the antigenic sites. While the data from these and other studies support the proposed linkage model, its rigorous proof will depend on the reconstitution of the proper polymer from J and monomer units, and the demonstration of a link between J and each heavy chain.
During the assembly process, the Jchain appears to be folded inside the polymers. The inhibition experiments showed that only one determinant in IgM and myeloma IgA and none in secretory IgA was available for reaction with antisera to the J chain. These data explain the usual failure to elicit antibodies to J chain after immunization with polymeric IgA or IgM and they suggest that an effective J antigen might be obtained by the partial denaturation or reduction of the polymers to increase the exposure of J determinants. The inhibition experiments also indicated that a different J determinant is exposed in IgM than in IgA. This result would be expected from the differences both in the structure of the pentamer and the dimer, and in the J linkage. However, since the same J chain is present in both polymers, the exposure of different determinants might also be important in maintaining the specific biological roles of the IgM and IgA classes.
The evidence that a specialized polypeptide chain induces the polymerization of other peptide chains is at present limited to the immunoglobulins. However, the use of such a chain would seem to offer an opportunity for controlled polymerization and added biological function. 
